1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,010 | 0,020 | 13:22 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| REVITALIST LIFESTYLE AND WELLNESS Aktie jetzt für 0€ handeln | |||||
| 18.02. | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Filing of Audited Financial Statements for the Year-Ended December 31, 2022 and Provides Update on Cease Trade Order | 349 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) (the "Company") wishes to announce that, further to... ► Artikel lesen |
1 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 82,00 | -0,04 % | Access Advance Applauds Historic Preliminary Injunction in German HEVC Enforcement Action Against Roku | BOSTON, MA / ACCESS Newswire / November 24, 2025 / Access Advance LLC today announced that one of its Licensors, Dolby International AB, has obtained a historic preliminary injunction from the Landgericht... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,084 | -2,33 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 87,80 | 0,00 % | Boston Scientific's Margins Strengthen in Q3: What's Driving It? | ||
| PAUL HARTMANN | 220,00 | -0,90 % | Januar bis September 2025: PAUL HARTMANN steigert Umsatz trotz schwächerer Absatzmärkte | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.826,0 Mio. EUR, organisches Umsatzwachstum von 2,0 % - Bereinigtes EBITDA liegt bei 195,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,7 % - Unternehmen... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,667 | +0,45 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update | Company reports progress to file planned IND for (Z)-endoxifen in mBC with CRO selection and streamlined development programs for potential 2026-NDA enabling activities... ► Artikel lesen | |
| EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| SENSEONICS | 5,000 | -3,94 % | XFRA 6L60: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| SYSMEX | 8,650 | -2,81 % | Sysmex verfehlt Q2-Prognosen - Aktie bricht ein | ||
| AFFINOR GROWERS | 0,009 | 0,00 % | CSE Bulletin: Suspensions - Affinor Growers Inc., Blackbird Critical Metals Corp. | Toronto, Ontario--(Newsfile Corp. - Le 7 octobre/October 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts... ► Artikel lesen | |
| ADDLIFE | 16,860 | +1,81 % | AddLife AB: Interim Report January 1 - September 30, 2025 | Good organic growth and strong earnings development"AddLife's companies performed strongly during the quarter. Organic growth was solid, margin improvement continued, earnings increased significantly... ► Artikel lesen | |
| EMBECTA | 11,600 | -1,69 % | Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance | PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month... ► Artikel lesen | |
| GENEDX | 167,52 | 0,00 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| PROGYNY | 26,770 | 0,00 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| ALIGNMENT HEALTHCARE | 19,150 | 0,00 % | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | ||
| CASTLE BIOSCIENCES | 39,930 | 0,00 % | Castle Biosciences: Starke Wachstumsdynamik und erhöhte Umsatzprognose |
Das Unternehmen REVITALIST LIFESTYLE AND WELLNESS LTD kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,015 Euro und damit -100,00 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu REVITALIST LIFESTYLE AND WELLNESS LTD finden Sie auf Wallstreet Online.